Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (31-40 of 256) with videos related to

Pageof 26
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Hanna Bonnekoh, Monique Butze, Martin Metz
Current Opinion in Allergy and Clinical Immunology|June 25, 2009
Mast cells: makers and breakers of allergic inflammationKayvan Hakim-Rad, Martin Metz, Marcus Maurer
JAAD Case Reports|August 17, 2021
Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumabThomas Buttgereit, Eva Maria Grekowitz, Martin Metz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2023
Livide Papeln an den distalen Extremitäten eines 14-jährigen MädchenHanna Bonnekoh, Alexander Nast, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 30, 2018
A Case of Muckle-Wells Syndrome due to novel NLRP3 mutationSimge Yuksel, Martin Metz, Peter Lohse, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 10, 2018
Ein Fall von Muckle-Wells-Syndrom mit einer neuen NLRP3-MutationSimge Yuksel, Martin Metz, Peter Lohse, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2019
Mast cells: Promoters of health and modulators of diseaseMarcus Maurer, Martin Köberle, Martin Metz, et al.
Clinical and Translational Allergy|January 13, 2017
Looking forward to new targeted treatments for chronic spontaneous urticariaEmek Kocatürk, Marcus Maurer, Martin Metz, et al.
The New England Journal of Medicine|February 6, 2020
Ligelizumab for Chronic Spontaneous Urticaria. ReplyMarcus Maurer, Ana M Giménez-Arnau, Martin Metz
JAMA|September 26, 2024
Chronic Spontaneous Urticaria: A ReviewPavel Kolkhir, Hanna Bonnekoh, Martin Metz, et al.
Pageof 26

Showing results (31-40 of 256) with videos related to

Sort By:
Pageof 26
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 11, 2022
Hanna Bonnekoh, Monique Butze, Martin Metz
Current Opinion in Allergy and Clinical Immunology|June 25, 2009
Mast cells: makers and breakers of allergic inflammationKayvan Hakim-Rad, Martin Metz, Marcus Maurer
JAAD Case Reports|August 17, 2021
Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumabThomas Buttgereit, Eva Maria Grekowitz, Martin Metz
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 14, 2023
Livide Papeln an den distalen Extremitäten eines 14-jährigen MädchenHanna Bonnekoh, Alexander Nast, Martin Metz, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 30, 2018
A Case of Muckle-Wells Syndrome due to novel NLRP3 mutationSimge Yuksel, Martin Metz, Peter Lohse, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 10, 2018
Ein Fall von Muckle-Wells-Syndrom mit einer neuen NLRP3-MutationSimge Yuksel, Martin Metz, Peter Lohse, et al.
The Journal of Allergy and Clinical Immunology|March 4, 2019
Mast cells: Promoters of health and modulators of diseaseMarcus Maurer, Martin Köberle, Martin Metz, et al.
Clinical and Translational Allergy|January 13, 2017
Looking forward to new targeted treatments for chronic spontaneous urticariaEmek Kocatürk, Marcus Maurer, Martin Metz, et al.
The New England Journal of Medicine|February 6, 2020
Ligelizumab for Chronic Spontaneous Urticaria. ReplyMarcus Maurer, Ana M Giménez-Arnau, Martin Metz
JAMA|September 26, 2024
Chronic Spontaneous Urticaria: A ReviewPavel Kolkhir, Hanna Bonnekoh, Martin Metz, et al.
Pageof 26